Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Fengwei Tan

Showing results (131-140 of 151) with videos related to

Pageof 16
Sort By:
Lung Cancer (Amsterdam, Netherlands)|June 24, 2022
External validation of the eighth edition of the TNM classification for lung cancer in small cell lung cancerFengwei Tan, Nan Bi, Hao Zhang, et al.
International Journal of Cancer|December 12, 2018
Independent and joint associations of blood lipids and lipoproteins with lung cancer risk in Chinese males: A prospective cohort studyZhangyan Lyu, Ni Li, Gang Wang, et al.
Cancer Science|March 14, 2020
Utility of isocitrate dehydrogenase 1 as a serum protein biomarker for the early detection of non-small-cell lung cancer: A multicenter in vitro diagnostic clinical trialNan Sun, Shouguo Sun, Yibo Gao, et al.
Cancer|May 24, 2023
Modifiable risk-attributable and age-related burden of lung cancer in China, 1990-2019Chenran Wang, Yuting Chang, Jingyu Ren, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 19, 2013
Isocitrate dehydrogenase 1 is a novel plasma biomarker for the diagnosis of non-small cell lung cancerNan Sun, Zhaoli Chen, Fengwei Tan, et al.
International Journal of Cancer|May 25, 2022
PSC subtyping based on TTF-1 and p40 expression reveals distinct molecular characteristics and therapeutic strategiesZhenlin Yang, He Tian, Lin Li, et al.
BMC Cancer|April 17, 2025
A study protocol for the CHinA National CancEr screening (CHANCES) trial: a randomized controlled study to compare the screening strategies for lung cancer and colorectal cancerYibo Gao, Ping Hu, Ning Wu, et al.
Nature Communications|September 27, 2023
Multimodal analysis of cell-free DNA whole-methylome sequencing for cancer detection and localizationFenglong Bie, Zhijie Wang, Yulong Li, et al.
Translational Lung Cancer Research|December 3, 2021
Menstrual factors, reproductive history, and risk of lung cancer: a multi-center population-based cohort study in Chinese femalesZhuoyu Yang, Fei Wang, Fengwei Tan, et al.
Cancer Medicine|May 18, 2023
A strategy to reduce the false-positive rate after low-dose computed tomography in lung cancer screening: A multicenter prospective cohort studyZheng Wu, Fengwei Tan, Yaozeng Xie, et al.
Pageof 16

Showing results (131-140 of 151) with videos related to

Sort By:
Pageof 16
Lung Cancer (Amsterdam, Netherlands)|June 24, 2022
External validation of the eighth edition of the TNM classification for lung cancer in small cell lung cancerFengwei Tan, Nan Bi, Hao Zhang, et al.
International Journal of Cancer|December 12, 2018
Independent and joint associations of blood lipids and lipoproteins with lung cancer risk in Chinese males: A prospective cohort studyZhangyan Lyu, Ni Li, Gang Wang, et al.
Cancer Science|March 14, 2020
Utility of isocitrate dehydrogenase 1 as a serum protein biomarker for the early detection of non-small-cell lung cancer: A multicenter in vitro diagnostic clinical trialNan Sun, Shouguo Sun, Yibo Gao, et al.
Cancer|May 24, 2023
Modifiable risk-attributable and age-related burden of lung cancer in China, 1990-2019Chenran Wang, Yuting Chang, Jingyu Ren, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 19, 2013
Isocitrate dehydrogenase 1 is a novel plasma biomarker for the diagnosis of non-small cell lung cancerNan Sun, Zhaoli Chen, Fengwei Tan, et al.
International Journal of Cancer|May 25, 2022
PSC subtyping based on TTF-1 and p40 expression reveals distinct molecular characteristics and therapeutic strategiesZhenlin Yang, He Tian, Lin Li, et al.
BMC Cancer|April 17, 2025
A study protocol for the CHinA National CancEr screening (CHANCES) trial: a randomized controlled study to compare the screening strategies for lung cancer and colorectal cancerYibo Gao, Ping Hu, Ning Wu, et al.
Nature Communications|September 27, 2023
Multimodal analysis of cell-free DNA whole-methylome sequencing for cancer detection and localizationFenglong Bie, Zhijie Wang, Yulong Li, et al.
Translational Lung Cancer Research|December 3, 2021
Menstrual factors, reproductive history, and risk of lung cancer: a multi-center population-based cohort study in Chinese femalesZhuoyu Yang, Fei Wang, Fengwei Tan, et al.
Cancer Medicine|May 18, 2023
A strategy to reduce the false-positive rate after low-dose computed tomography in lung cancer screening: A multicenter prospective cohort studyZheng Wu, Fengwei Tan, Yaozeng Xie, et al.
Pageof 16